PD-Rx Phentermine Recall: Impurity Issues in 15 mg Capsules
PD-Rx recalls 15 mg Phentermine capsules due to failed impurity specifications. Check lot numbers and expiration dates for affected bottles.
Recall notice
Failed impurities/Degradation specifications: out of specification results for individual unknown and total impurity at the 12th month room temperature stability test station
Contact the company
What happened, in plain English
PD-Rx Pharmaceuticals is recalling specific lots of Phentermine Hydrochloride Capsules, USP, 15 mg because they contain out-of-specification levels of unknown and total impurities. The issue was identified during stability testing at the 12-month room temperature mark. This recall affects 1,685 bottles distributed nationwide. Read more at govinfonow.com/recall/44006-pd-rx-pharmaceuticals-inc-recalls-phentermine-hydrochloride-capsules-usp-15.
Source Summary by GovInfoNow · govinfonow.com/recall/44006-pd-rx-pharmaceuticals-inc-recalls-phentermine-hydrochloride-capsules-usp-15 · Updated October 12, 2026 · FDA enforcement record: FDA #D-0574-2016
Cite this page
“PD-Rx Phentermine Recall: Impurity Issues in 15 mg Capsules.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44006-pd-rx-pharmaceuticals-inc-recalls-phentermine-hydrochloride-capsules-usp-15. Based on FDA recall #D-0574-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0574-2016%22&limit=1).
Why it’s dangerous
The recalled capsules failed impurity specifications, meaning they contain higher-than-allowed levels of unknown and total impurities. The record does not specify what these impurities are or the specific health risks they pose to consumers.
Who’s affected
Consumers who purchased Phentermine Hydrochloride Capsules, USP, 15 mg from PD-Rx Pharmaceuticals between the manufacturing dates and expiration dates listed in the record. Individuals relying on this specific medication for weight management may be affected.
How to tell if you have this one
Look for Phentermine Hydrochloride Capsules, USP, 15 mg packaged by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK. Affected items include 7-count (NDC 55289-791-07), 14-count (NDC 55289-791-14), 28-count (NDC 55289-791-28), 30-count (NDC 55289-791-30), and 60-count (NDC 55289-791-60) bottles. Check the lot numbers and expiration dates against the record: Lot H14C80 (Exp 08/16), I14G36 (Exp 09/16), H14A86 (Exp 07/16), H14C83 (Exp 08/16), K14A21 (Exp 11/16), H14F25 (Exp 08/16), and L14C42 (Exp 12/16).
- Brand
PD-Rx Pharmaceuticals- Category
Drug
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 17 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0574-2016 (July 21, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0574-2016 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.